Bristol-Meyers Squibb Acquires Amira Pharmaceuticals for $475,000,000

  • Feed Type
  • Date
    7/21/2011
  • Company Name
    Amira Pharmaceuticals
  • Mailing Address
    9535 Waples Street San Diego, CA 92121
  • Company Description
    Amira Pharmaceuticals is a privately-held biopharmaceutical company, focused on leveraging the deep expertise of a team of scientists in the field of inflammatory diseases.
  • Website
    http://www.amirapharm.com
  • Transaction Type
    M&A
  • Transaction Amount
    $475,000,000
  • Transaction Round
  • Proceeds Purposes
  • M&A Terms
    Bristol-Myers Squibb will acquire all of Amira Pharmaceuticals’ issued and outstanding shares of capital stock and stock equivalents in an all-cash transaction for a purchase price of $325 million upfront and potential additional milestone payments totaling $150 million.

By posting a comment, you agree to our terms and conditions.